WHO ICTRP trial
A multicenter real world study: bicyclol tablets for the prevention and…
ChiCTR2200062246 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2200062246 |
|---|---|
| Public title | A multicenter real world study: bicyclol tablets for the prevention and treatment of liver injury associated with drugs in the treatment of hematologic malignancies |
| Scientific title | A multicenter real world study: bicyclol tablets for the prevention and treatment of liver injury associated with drugs in the treatment of hematologic malignancies |
| Primary sponsor | Institute of Hematology & Oncology, Harbin First Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Countries | China |
| Conditions | Drug induced liver injury |
| Interventions | Case series:bicyclol tablets |
| Registration date | Jul 31, 2022 |
| Target size | Case series:2500 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: